Literature DB >> 35031946

The modulation of neuroinflammation by inducible nitric oxide synthase.

Alberto Fernando Oliveira Justo1, Claudia Kimie Suemoto2,3.   

Abstract

The accumulation and propagation of misfolded proteins in the brain is a pathological hallmark shared by many neurodegenerative diseases, such as the depositions of β-amyloid and hyperphosphorylated tau proteins in Alzheimer's disease. Initial evidence shows the role of nitric oxide synthases in the development of neurodegenerative diseases. A recent, in an exciting paper (Bourgognon et al. in Proc Natl Acad Sci USA 118, 1-11, 2021. 10.1073/pnas.2009579118) it was shown that the inducible nitric oxide synthase plays an important role in promoting oxidative and nitrergic stress leading to neuroinflammation and consequently neuronal function impairments and decline in synaptic strength in mouse prion disease. In this context, we reviewed the possible mechanisms of nitric oxide synthase in the generation of neurodegenerative diseases.
© 2021. The International CCN Society.

Entities:  

Keywords:  Neurodegeneration; Nitrergic stress; Oxidative stress; Prion model; iNOS

Year:  2022        PMID: 35031946      PMCID: PMC8891402          DOI: 10.1007/s12079-021-00663-x

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.908


  22 in total

1.  Autonomic dysregulation at multiple sites is implicated in age-associated underactive bladder in female mice.

Authors:  Mariana Gonçalves de Oliveira; Eduardo Costa Alexandre; Sandra Milena Bonilla-Becerra; Gabriela Maria Bertollotto; Alberto Fernando Oliveira Justo; Fabiola Zakia Mónica; Edson Antunes
Journal:  Neurourol Urodyn       Date:  2019-04-01       Impact factor: 2.696

Review 2.  Oxidative Stress and the Central Nervous System.

Authors:  Samina Salim
Journal:  J Pharmacol Exp Ther       Date:  2016-10-17       Impact factor: 4.030

Review 3.  The global prevalence of dementia: a systematic review and metaanalysis.

Authors:  Martin Prince; Renata Bryce; Emiliano Albanese; Anders Wimo; Wagner Ribeiro; Cleusa P Ferri
Journal:  Alzheimers Dement       Date:  2013-01       Impact factor: 21.566

4.  The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.

Authors:  R Boer; W R Ulrich; T Klein; B Mirau; S Haas; I Baur
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

Review 5.  Nitric oxide signaling in brain function, dysfunction, and dementia.

Authors:  Joern R Steinert; Tatyana Chernova; Ian D Forsythe
Journal:  Neuroscientist       Date:  2010-08       Impact factor: 7.519

Review 6.  3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases.

Authors:  Maria Bandookwala; Pinaki Sengupta
Journal:  Int J Neurosci       Date:  2020-01-21       Impact factor: 2.292

7.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

8.  Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress.

Authors:  Subramanian Kumar; Pichavaram Prahalathan; Boobalan Raja
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-19       Impact factor: 3.000

Review 9.  Inducible nitric oxide synthase inhibitors: A comprehensive update.

Authors:  Richa Minhas; Yogita Bansal; Gulshan Bansal
Journal:  Med Res Rev       Date:  2019-09-10       Impact factor: 12.944

10.  VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.

Authors:  Mauro Siragusa; Alberto Fernando Oliveira Justo; Pedro Felipe Malacarne; Anna Strano; Akshay Buch; Barbara Withers; Kevin G Peters; Ingrid Fleming
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

View more
  1 in total

1.  Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms.

Authors:  Marcin P Mycko; Anna E Zurawska; Igor Selmaj; Krzysztof W Selmaj
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.